Wells Fargo Downgrades Biogen (BIIB) to Market Perform, Expects Equity to Trade Rang-Bound

March 21, 2019 9:16 AM
Wells Fargo downgraded Biogen (NASDAQ: BIIB) from Outperform to Market Perform.The analyst comments "We expect BIIB to remain range-bound ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles